Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Medical oncology · Sun Yat-sen Memorial Hospital, Sun Yat-sen University · Guangzhou

Dr. Li Jing李晶

Chief Physician · Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Li Jing

Professional overview

Dr. Li Jing is a Chief Physician in the Department of Gynecologic Oncology at Sun Yat-sen Memorial Hospital, Sun Yat-sen University, specializing in surgical and comprehensive management of gynecologic malignancies, with particular focus on hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery.

SpecialtyMedical oncology
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentGynecologic Oncology
HospitalSun Yat-sen Memorial Hospital, Sun Yat-sen University
CityGuangzhou

Areas of focus

Hyperthermic intraperitoneal chemotherapy (HIPEC)Used in combination with multi-organ resection for high-burden advanced ovarian cancer, peritoneal carcinomatosis, and peritoneal sarcomatosis
Cytoreductive surgeryFor advanced and complex gynecologic cancers, especially late-stage ovarian cancer

Background

  • 2020Published predictive nomogram for chemotherapy response score 3 in Frontiers in Oncology
  • 2020Presented effects of neoadjuvant HIPEC on chemotherapy response score at Annals of Oncology (ESMO Congress)
  • 2021Published clinical trial protocol for neoadjuvant HIPEC in advanced high-grade serous ovarian cancer (NHIPEC trial) in BMJ Open
  • 2021Published research on cisplatin dosing in HIPEC for ovarian cancer in Journal of Ovarian Research
  • 2021Published dose-finding trial for HIPEC cisplatin in gynecologic cancers in Frontiers in Oncology

Experience & recognition

  • Lead author of Chinese Anti-Cancer Association (CACA) guidelines and expert consensus on HIPEC in gynecologic oncology (4 consecutive years)
  • Principal investigator of multiple clinical studies on HIPEC and cytoreduction
  • Published 27 SCI papers; findings adopted by ASCO and Asian guidelines
  • Designated as the only CACA-authorized training base for standardized HIPEC application in gynecologic oncology
  • Designated as principal responsible person for the National Health Commission's restricted technique training base for deep regional and whole-body hyperthermia

Professional roles

  • Vice Chair, Peritoneal Tumor Society, China Anti-Cancer Association (CACA)
  • Vice Chair, Ovarian Cancer Society, Guangzhou Anti-Cancer Association
  • International Coordinator, Japan Society of Clinical Oncology
  • Vice Chair, Youth Committee of Gynecologic Oncology Branch, Guangdong Medical Association

Frequently asked questions

What does Dr. Li Jing specialize in?

Specializes in surgical treatment of ovarian, cervical, and endometrial cancers — especially cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for advanced ovarian cancer and peritoneal malignancies; and comprehensive systemic therapy for unresectable or recurrent disease, including chemotherapy, targeted therapy, anti-angiogenic therapy, and immunotherapy.

Which hospital and department is Dr. Li Jing in?

Department of Gynecologic Oncology at Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Sources

Dr. Li Jing has not reviewed this page.